Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001789617-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
21
Total Shares
799,567
Total Value
$21,907,918.34
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 39,283 | $26.88 | $1,055,927.04 | 181,349 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 1,381 | $22.40 | $30,934.40 | 182,730 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 36,526 | $8.93 | $326,177.18 | 219,256 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 71,938 | $62.05 | $4,463,875.19 | 147,318 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 27,421 | $62.59 | $1,716,379.11 | 119,897 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 1,400 | $63.65 | $89,112.94 | 118,497 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 1,431 | $65.31 | $93,457.61 | 117,066 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 100,000 | $11.25 | $1,125,000.00 | 217,066 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 55,000 | $15.46 | $850,300.00 | 272,066 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 17,717 | $26.88 | $476,232.96 | 289,783 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 16, 2026 | Sale | 93,604 | $63.25 | $5,920,181.55 | 196,179 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 16, 2026 | Sale | 79,113 | $63.65 | $5,035,906.37 | 117,066 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 17, 2026 | Exercise/Conversion | 8,282 | $22.40 | $185,516.80 | 125,348 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 8,282 | $65.07 | $538,917.19 | 117,066 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 39,283 | $0.00 | $0.00 | 18,217 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 1,381 | $0.00 | $0.00 | 53,119 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 36,526 | $0.00 | $0.00 | 28,474 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 100,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 55,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 17,717 | $0.00 | $0.00 | 500 | Direct | โ | View Details | |
EVP, CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 17, 2026 | Exercise/Conversion | 8,282 | $0.00 | $0.00 | 44,837 | Direct | โ | View Details |